You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美單日新增逾8萬宗新冠確診 司法部就暫停接種疫苖規定上訴
阿思達克 11-10 16:02
美國新冠疫情持續。據美國約翰霍普金斯大學統計,美國截至西岸時間午夜(本港時間下午4時)累計確診46,694,791宗,單日新增81,581宗。累計新冠死亡個案757,406宗,單日新增1,763宗。 美國藥廠輝瑞及德國生物科技公司BioNTech已向美國食品及藥物管理局提出申請,要求批準在成年人接種第三劑「復必泰」。公司發聲明稱,針對1萬名參與者的第三期臨牀測試顯示,第三劑疫苗對新冠預防有效率達95%。 美國司法部就美國聯邦法院暫停執行美國總統拜登的強制接種疫苗規定提出上訴,指暫停規定生效只會延續疫情,與及每日數以十計甚至百計死亡。該規定適用於逾僱用逾100名員工的私人機構,有關員工明年1月4日起若未接種疫苗,即須戴口罩及每週接受檢測。 下表爲美國過去八日每日新冠疫情統計: 日期│累計確診│單日新增確診│累計死亡│單日新增死亡 11月 9日(二)│46,694,791宗│+ 81,581宗│757,406宗│+1,763宗 11月 8日(一)│46,613,210宗│+125,402宗│755,643宗│+1,213宗 11月 7日(日)│46,487,808宗│+ 26,058宗│754,430宗│+ 151宗 11月 6日(六)│46,461,750宗│+ 25,685宗│754,279宗│+ 349宗 11月 5日(五)│46,436,065宗│+101,183宗│753,930宗│+2,375宗 11月 4日(四)│46,334,882宗│+ 82,333宗│751,555宗│+1,129宗 11月 3日(三)│46,252,549宗│+ 83,537宗│750,426宗│+1,908宗 11月 2日(二)│46,169,012宗│+ 77,088宗│748,518宗│+1,485宗
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account